{"schema_version":"1","generated_at":"2026-11-03T19:40:05.723Z","data_as_of":null,"url":"https://www.findmykol.com/kol/glenn-kroog","json_url":"https://www.findmykol.com/kol/glenn-kroog/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"glenn-kroog","name":"Glenn Kroog","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Regeneron","institution_url":"https://www.findmykol.com/institution/regeneron","city":"New York","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1689798969","orcid":"0009-0000-2897-9810","openalex":"A5071551404"},"summary":"Glenn Kroog is an Oncology physician affiliated with Regeneron. OpenAlex indexes 148 publications with 2,267 citations (h-index 23); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":148,"cited_by_count":2267,"h_index":23,"latest_activity_year":2025,"emerging":true,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT00459875","title":"Sunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"Memorial Sloan Kettering Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT00459875","trial_url":"https://www.findmykol.com/trial/NCT00459875"},{"nct":"NCT00422344","title":"A Study of RAD001 and Sunitinib in Metastatic Renal Cell Carcinoma","phase":"PHASE1","status":"COMPLETED","role":"Overall official","sponsor":"Memorial Sloan Kettering Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT00422344","trial_url":"https://www.findmykol.com/trial/NCT00422344"}],"source":"trials"},"funding":{"award_count":1,"fiscal_years":{"first":2003,"last":2005},"rows_total":3,"shown":3,"withheld":0,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"K22CA098102","title":"GRP Receptor Signaling: Role of the C-Terminal Domain","fiscal_year":2005,"amount_usd":"159300","organization":"ALBERT EINSTEIN COL OF MED YESHIVA UNIV","source_url":"https://reporter.nih.gov/quickSearch/K22CA098102"},{"project":"K22CA098102","title":"GRP Receptor Signaling: Role of the C-Terminal Domain","fiscal_year":2004,"amount_usd":"159300","organization":"ALBERT EINSTEIN COL OF MED YESHIVA UNIV","source_url":"https://reporter.nih.gov/quickSearch/K22CA098102"},{"project":"K22CA098102","title":"GRP Receptor Signaling: Role of the C-Terminal Domain","fiscal_year":2003,"amount_usd":"159300","organization":"YESHIVA UNIVERSITY","source_url":"https://reporter.nih.gov/quickSearch/K22CA098102"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Linvoseltamab in Patients With Relapsed/Refractory Multiple Myeloma in the LINKER-MM1 Study: Longer Follow-Up and Subgroup Analyses","year":2025,"journal":"Clinical Lymphoma Myeloma & Leukemia","source_url":"https://doi.org/10.1016/j.clml.2025.11.004","status":"verified"},{"title":"Indirect Comparison of Linvoseltamab Versus Teclistamab for the Treatment of Triple-Class Exposed Relapsed/Refractory Multiple Myeloma","year":2025,"journal":"Clinical Lymphoma Myeloma & Leukemia","source_url":"https://doi.org/10.1016/j.clml.2025.06.014","status":"verified"},{"title":"Safety and efficacy of linvoseltamab as a simplified monotherapy first-line regimen in NDMM: Initial Results from the window of opportunity Phase 1/2 LINKER-MM4 trial","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-697","status":"verified"},{"title":"Safety and Efficacy of Linvoseltamab (LINVO) in Patients (Pts) with High-risk Smoldering Multiple Myeloma (HR-SMM): First Results from the Phase 2 LINKER-SMM1 Trial","year":2025,"journal":"Clinical Lymphoma Myeloma & Leukemia","source_url":"https://doi.org/10.1016/s2152-2650(25)04011-x","status":"verified"},{"title":"Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma","year":2024,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.24.01008","status":"verified"}],"source":"works"},"contact":{"address_1":"MEMORIAL SLOAN-KETTERING CANCER CENTER","address_2":"1275 YORK AVENUE","city":"New York","state":"NY","zip":"10065","phone":"646-422-4313","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1689798969","source":"identity"},"similar":[{"name":"Allen Radin","slug":"allen-radin","institution":"Regeneron","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/allen-radin","json_url":"https://www.findmykol.com/kol/allen-radin/profile.json"},{"name":"Ofri Mosenzon","slug":"ofri-mosenzon","institution":"Regeneron","url":"https://www.findmykol.com/kol/ofri-mosenzon","json_url":"https://www.findmykol.com/kol/ofri-mosenzon/profile.json"},{"name":"Nikhil Amin","slug":"nikhil-amin","institution":"Regeneron","specialty":"Pediatric Pulmonology","url":"https://www.findmykol.com/kol/nikhil-amin","json_url":"https://www.findmykol.com/kol/nikhil-amin/profile.json"},{"name":"Thomas Uldrick","slug":"thomas-uldrick","institution":"Regeneron","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/thomas-uldrick","json_url":"https://www.findmykol.com/kol/thomas-uldrick/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2007-08-21","collected_at":"2026-11-03T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}